New York legislation · 2025-2026 General Assembly
New York S1913: Relates to establishing the "340B prescription drug anti-discrimination act"
Status: In committee, June 5, 2026
Relates to establishing the "340B prescription drug anti-discrimination act"; prohibits pharmaceutical manufacturers and pharmacy benefit managers from discriminating against covered entities and New York state pharmacies based on participation in the drug discount program authorized by section 340B of the federal public health service act.
What the bill says
An act to amend the public health law, in relation to establishing the 340B prescription drug anti-discrimination act.
From the introduced text, January 14, 2025:
AN ACT to amend the public health law, in relation to establishing the 340B prescription drug anti-discrimination act THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS: Section 1. Short title. This act shall be known and may be cited as the "340B prescription drug anti-discrimination act". § 2. The public health law is amended by adding a new section 280-d to read as follows: § 280-D. PRESCRIPTION DRUG DISCRIMINATION PROHIBITED. 1. DEFINITIONS. (A) "340B PROGRAM" SHALL MEAN THE DRUG DISCOUNT PROGRAM AUTHORIZED BY SECTION 340B OF THE FEDERAL PUBLIC HEALTH SERVICE ACT (42 U.S.C. § 256B). (B) "COVERED ENTITY" SHALL HAVE THE SAME MEANING AS IS SET FORTH IN SECTION 340B(A)(4) OF THE FEDERAL PUBLIC HEALTH SERVICE ACT (42 U.S.C. § 256B). (C) "CONTRACT PHARMACY" SHALL INCLUDE NEW YORK STATE PHARMACIES THAT RECEIVE DRUGS PURCHASED UNDER A CONTRACT PHARMACY ARRANGEMENT WITH A COVERED ENTITY. (D) "DISPENSING" SHALL INCLUDE A PHARMACY'S ENTIRE DISTRIBUTION PROCESS, INCLUDING, BUT NOT LIMITED TO, THE ORDERING, PURCHASING, DELIVERING, RECEIPT, AND SALE OF DRUGS. (E) "PHARMACY" SHALL HAVE THE SAME MEANING AS IS SET FORTH IN SECTION SIXTY-EIGHT HUNDRED TWO OF THE EDUCATION LAW. 2. PROHIBITION OF DISCRIMINATORY PRACTICE. NO PHARMACEUTICAL MANUFACTURER, PHARMACY BENEFIT MANAGER, OUTSOURCING FACILITY, OR THIRD-PARTY LOGISTICS PROVIDER SHALL DIRECTLY OR INDIRECTLY: (A) DENY, PROHIBIT, …
Sponsors
- Gustavo Rivera (D, 33) · primary sponsor
- Joseph Addabbo (D, 15)
- April Baskin (D, 63)
- Samra Brouk (D, 55)
- Cordell Cleare (D, 30)
- Leroy Comrie (D, 14)
- Jeremy Cooney (D, 56)
- Patricia Fahy (D, 46)
- Nathalia Fernandez (D, 34)
- Kristen Gonzalez (D, 59)
- Peter Harckham (D, 40)
- Michelle Hinchey (D, 41)
Latest actions
- : REFERRED TO HEALTH
- : DELIVERED TO ASSEMBLY
- : PASSED SENATE
- : ADVANCED TO THIRD READING
- : 2ND REPORT CAL.
- : 1ST REPORT CAL.595
- : REPORTED AND COMMITTED TO FINANCE
- : REFERRED TO HEALTH
- : REPORTED AND COMMITTED TO FINANCE
- : REFERRED TO HEALTH
Votes
- FLOOR Vote (June 4, 2026): 48 yea, 12 nay, passed
- Senate Finance Committee: COMMITTEE Vote (March 24, 2026): 22 yea, 0 nay, passed
- Finance Committee Vote (March 24, 2026): 22 yea, 0 nay, passed
- Senate Health Committee: COMMITTEE Vote (January 27, 2026): 14 yea, 0 nay, passed
- Health Committee Vote (January 27, 2026): 14 yea, 0 nay, passed
- Senate Health Committee: COMMITTEE Vote (February 4, 2025): 14 yea, 1 nay, passed
Subjects: Public Health Law
Common questions
- What is S1913?
- S1913 is a bill in the New York Legislature (2025-2026 General Assembly): Relates to establishing the "340B prescription drug anti-discrimination act".
- What does S1913 do?
- In its own words: An act to amend the public health law, in relation to establishing the 340B prescription drug anti-discrimination act.
- What is the status of S1913?
- In committee as of June 5, 2026. Latest action: REFERRED TO HEALTH (June 5, 2026).
- Who sponsored S1913?
- Gustavo Rivera (D, 33), with 11 co-sponsors.
- Where is the official record for S1913?
- On the New York Legislature website: https://www.nysenate.gov/legislation/bills/2025/S1913
Source: official New York record. Tracked by Delilah, AI for legislation across all 50 states and Congress.